Clinical Trial Update: A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma. [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study evaluating a single-dose, double-blind design in healthy subjects and individuals with mild atopic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Amgen | Conditions: Asthma | Phase 1 | Status: COMPLETED